Possible common origin of α-fetoprotein- and human chorionic gonadotropin—secreting cells in intracranial germ cell tumor

1998 ◽  
Vol 88 (3) ◽  
pp. 576-580 ◽  
Author(s):  
Haruhiko Kishima ◽  
Keiji Shimizu ◽  
Yasuyoshi Miyao ◽  
Eiichiro Mabuchi ◽  
Toru Hayakawa

✓ A primary intracranial germ cell tumor in a 16-year-old boy secreted both a-fetoprotein (AFP) and human chorionic gonadotropin (HCG). The tumor, located in the right thalamus, contained germinomatous, trophoblastic, and endodermal sinus components. To identify AFP- and HCG-secreting cells, germ cells from the surgical specimen were cultured in vitro. These cultured cells secreted AFP and HCG for 10 weeks, and immunohistochemical studies showed that some of the cells secreted both AFP and HCG. These findings suggest that multipotential germ cells migrate to the encephalic region and may become germ cell tumors containing various types of tissue.

2013 ◽  
Vol 155 (6) ◽  
pp. 1037-1038 ◽  
Author(s):  
P. Bourdillon ◽  
D. Frappaz ◽  
A. Vasiljevic ◽  
E. Jouanneau

Cancer ◽  
1978 ◽  
Vol 41 (6) ◽  
pp. 2315-2320 ◽  
Author(s):  
B. Nørgaard-Pedersen ◽  
J. Lindholm ◽  
R. Albrechtsen ◽  
J. Riishede ◽  
J. Arends ◽  
...  

1984 ◽  
Vol 18 (2) ◽  
pp. 240-246 ◽  
Author(s):  
Su-Cheng Huang ◽  
Hao-Chia Chen ◽  
Robert J. Kurman ◽  
Yu-Shih Yang ◽  
Hsi-Kwei Wen ◽  
...  

2019 ◽  
Vol 1 (Supplement_2) ◽  
pp. ii23-ii23
Author(s):  
Kaishi Satomi ◽  
Hirokazu Takami ◽  
Shintaro Fukushima ◽  
Yoichi Nakazato ◽  
Shota Tanaka ◽  
...  

Abstract BACKGROUND Gain of short arm of chromosome 12 (12p) is commonly observed in testicular germ cell tumors (tGCTs). 12p gain is also frequently seen in intracranial GCTs (iGCTs). However, little is known about the clinical significance of 12p gain in iGCTs. MATERIALS AND METHODS We have collected over 200 fresh frozen tissue samples of iGCTs through the Intracranial Germ Cell Tumor Genome Analysis Consortium in Japan. Firstly, we analyzed DNA methylation status in 83 iGCTs, 3 seminomas and 6 normal control samples using Infinium Human Methylation 450K BeadChip array (Illumina, CA). Idat files were processed using R (Version 3.5.3) and minfi package (1.30.0) to generate copy number variations. Compared with average genome-wide copy number level, 12p gain was determined. Then, 58 iGCTs with clinicopathological information were analyzed for progression-free survival (PFS) and overall survival (OS). Those tumors that consist of only either germinoma and/or mature teratoma components were classified as Favorable Histology (FH) and all the others that contains malignant histological components were classified as Unfavorable Histology (UFH). RESULT 12p gain was observed in 100% (3/3) of seminoma, 13.6% (3/22) of germinoma, 16.7% (1/6) of mature teratoma, 25% (1/4) of immature teratoma, 55% (11/20) of mixed germ cell tumor, 100% (4/4) of yolk sac tumor, 100% (1/1) of embryonal carcinoma, and 100% (1/1) of choriocarcinoma. In total, 44.6% (37/83) of iGCT showed 12p gain. Regarding histological classification, the 12p gain rate in UFH (72%, 18/25) was significantly higher than that in FH (12.1%, 4/33, P<0.01). Both PFS and OS were significantly worse in iGCTs with 12p gain (PFS: P=0.027, OS: P=0.0012). DISCUSSION 12p gain can be a molecular marker to predict prognosis and histological malignancy in iGCTs.


Sign in / Sign up

Export Citation Format

Share Document